0000899243-20-033167.txt : 20201209
0000899243-20-033167.hdr.sgml : 20201209
20201209160510
ACCESSION NUMBER: 0000899243-20-033167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201208
FILED AS OF DATE: 20201209
DATE AS OF CHANGE: 20201209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'Cruz Cony
CENTRAL INDEX KEY: 0001797727
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 201377895
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-08
0
0001490978
Schrodinger, Inc.
SDGR
0001797727
D'Cruz Cony
C/O SCHRODINGER, INC.,
120 WEST 45TH STREET, 17TH FLOOR
NEW YORK
NY
10036
0
1
0
0
See Remarks
Common Stock
2020-12-08
4
M
0
1114
4.34
A
1114
D
Common Stock
2020-12-08
4
M
0
871
2.92
A
1985
D
Common Stock
2020-12-08
4
M
0
2389
3.07
A
4374
D
Common Stock
2020-12-08
4
S
0
4374
67.47
D
0
D
Common Stock
2020-12-08
4
S
0
2000
67.47
D
167082
I
By Cony and Pearl D'Cruz Revocable Trust dated August 20, 2019, and any amendments thereto
Stock Option (right to buy)
4.34
2020-12-08
4
M
0
1114
0.00
D
2028-11-29
Common Stock
1114
18951
D
Stock Option (right to buy)
2.92
2020-12-08
4
M
0
871
0.00
D
2027-06-01
Common Stock
871
2933
D
Stock Option (right to buy)
3.07
2020-12-08
4
M
0
2389
0.00
D
2026-05-10
Common Stock
2389
31054
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2020.
This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
This option was granted on June 1, 2017. The shares underlying the option are scheduled to vest in equal yearly installments from January 1, 2017 through January 1, 2021.
The option was granted on May 11, 2016 and is fully vested.
Executive Vice President and Chief Business Officer
/s/ Donald Shum, as attorney-in-fact for Cony D'Cruz
2020-12-09